Is Kronos Bio, Inc. (KRON) a Buy, Sell, or Hold?
NASDAQ : KRON
Kronos Bio, Inc.
$0.88 USD
$0.01 (1.49%)
- Volume
- 53.69K
- Average Volume
- 855.96K
- Market Capitalization
- $53.65M
- P/E Ratio
- -0.62
- Dividend Yield
- 0.00%
- Price Target
- $1.63
- Year High
- $1.46
- Year Low
- $0.65
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $7.54
Company Overview
NASDAQ
Deborah A. Knobelman
Biotechnology
Healthcare
KRON
8
US
USD
Liquidity Metrics
0.28
7.54
7.54
5.54
0.00
Sales & Valuation
$9.85M
5.45
0.60
-0.82
-1.09
Profitability
-$1.43
-$86.08M
-874.08%
-874.08%
-69.80%
-69.22%
P/E Metrics
-0.62
-0.01
-0.01
Analyst Price Target & Rating
$1.63
$2.25
$1.00
0/5
5 Analysts
-45.85%
Poll Results
About Kronos Bio, Inc. (NASDAQ:KRON) Stock
Kronos Bio, Inc. is a biopharmaceutical firm operating at the clinical stage, dedicated to the identification and advancement of innovative therapies for cancer. Its therapeutic strategy centers on modulating dysregulated transcription factors and the intricate transcriptional regulatory networks that fuel oncogenic activity. The company's primary investigational drug, entospletinib (ENTO), is an orally administered, selective inhibitor of spleen tyrosine kinase (SYK), designed for patients with acute myeloid leukemia. A registrational Phase 3 clinical trial is slated to evaluate ENTO in combination with induction chemotherapy for acute myeloid leukemia patients who possess NPM1 mutations. Furthermore, Kronos Bio is progressing KB-0742, an orally bioavailable cyclin dependent kinase 9 (CDK ... 9) inhibitor, which is currently undergoing Phase 1/2 clinical assessment for the treatment of MYC-amplified solid tumors. Established in 2017, the company maintains its headquarters in San Mateo, California.
Frequently Asked Questions
-
What is the current Kronos Bio, Inc. (KRON) stock price?
-
Kronos Bio, Inc.(NASDAQ:KRON) stock price is $0.88 in the last trading session. During the trading session, KRON stock reached the peak price of $1.46 while $0.65 was the lowest point it dropped to. The percentage change in KRON stock occurred in the recent session was 1.49% while the dollar amount for the price change in KRON stock was $0.01.
-
KRON's industry and sector of operation?
-
The NASDAQ listed KRON is part of Biotechnology industry that operates in the broader Healthcare sector.
-
Who are the executives of KRON?
-
Deborah A. Knobelman | Interim Chief Executive Officer, Chief Financial Officer, Chief Operating Officer & President
David Tanen | Secretary & Director
Joshua A. Kazam | Co-Founder & Director
|
| -
How many employees does KRON have?
-
Number of KRON employees currently stands at 8. KRON operates from 1300 South El Camino Real, San Mateo, CA 94402, US.
-
Link for KRON official website?
-
Official Website of KRON is: https://kronosbio.com
-
How do I contact KRON?
-
KRON could be contacted at phone #650 781 5200 and can also be accessed through its website. KRON operates from 1300 South El Camino Real, San Mateo, CA 94402, US.
-
How many shares of KRON are traded daily?
-
The average number of KRON shares traded daily for last 3 months was 855.96K.
-
What is the market cap of KRON currently?
-
The market value of KRON currently stands at $53.65M with its latest stock price at $0.88